近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Detection of Bladder Cancer by Fluorescence Cystoscopy: From Bench to Bedside - the Hexvix Story. G. Wagnières, P. Jichlinski, N. Lange, P. Kucera and H. Van den Bergh. in Handbook of Photomedicine, num. 978-1-4398-8470-6, p. 411-426, 2014. Temperature and oxygen-concentration dependence of singlet oxygen production by RuPhen as induced by quasi-continuous excitation. J. Varchola, V. Huntosova, D. Jancura, G. Wagnieres, P. Miskovsky and G. Bano. in Photochem. Photobiol. Sci., 2014. Low-Dose Vascular Photodynamic Therapy Decreases Tumor Interstitial Fluid Pressure, which Promotes Liposomal Doxorubicin Distribution in a Murine Sarcoma Metastasis Model. J. Y. Perentes, Y. Wang, X. Wang, E. Abdelnour, M. Gonzalez, L. Decosterd, G. Wagnieres, H. van den Bergh, S. Peters, H.-B. Ris and T. Krueger. in Translational oncology, 2014. In vivo measurement of tissue oxygenation by time-resolved luminescence spectroscopy: advantageous properties of dichlorotris(1, 10-phenanthroline)-ruthenium(II) hydrate. V. Huntosova, S. Gay, P. Nowak-Sliwinska, S. K. Rajendran, M. Zellweger, H. Van Den Bergh and G. Wagnières. in Journal of Biomedical Optics, vol. 19, num. 7, p. 077004, 2014. Optical spectroscopy of the bladder washout fluid to optimize fluorescence cystoscopy with Hexvix. C. Martoccia, M. Zellweger, B. Lovisa, P. Jichlinski, H. Van Den Bergh and G. Wagnières. in Journal of Biomedical Optics, vol. 19, num. 9, p. 097002, 2014. Light dose plays a critical role for the distribution of chemotherapy and tumor response in mesothelioma xenografts pre-treated by photodynamic therapy. J. Y. Perentes, X. Wang, Y. Wang, M.-A. Le Bitoux, G. Wagnieres, H. Vandenbergh, M. Gonzalez, H.-B. Ris and T. Krueger. 101st Annual Congress of the Swiss-Society-of-Surgery. Detection of Bladder Cancer by Fluorescence Cystoscopy: From Bench to Bedside - the Hexvix Story. G. Wagnières, P. Jichlinski, N. Lange, P. Kucera and H. van den Bergh; (Ed.). Taylor & Francis. , 978-1-4398-8469-0, Handbook of Photomedicine. Study of the stability of the 5-aminolevulinic acid tyrosine ester in aqueous solution. S. Gay, C. Martoccia, M. Zellweger, Q. Wang and G. Wagnières. in ARKIVOC - Online Journal of Organic Chemistry, vol. 2014, num. 3, p. 228-238, 2014. Correlation between Protoporphyrin IX Fluorescence Intensity, Photobleaching, Pain and Clinical Outcome of Actinic Keratosis Treated by Photodynamic Therapy. F. Piffaretti, M. Zellweger, B. Kasraee, J. Barge, D. Salomon, H. Van Den Bergh and G. Wagnières. in Dermatology, vol. 227, num. 3, p. 214-225, 2013. Correlations between photoactivable porphyrins’ fluorescence, erythema and the pain induced by PDT on normal skin using ALA-derivatives. J. Barge, T. Glanzmann, M. Zellweger, D. Salomon, H. Van Den Bergh and G. Wagnières. in Photodiagnosis and Photodynamic Therapy, vol. 10, num. 4, p. 683-693, 2013. Near-Infrared 808 nm Light Boosts Complex IV-Dependent Respiration and Rescues a Parkinson-Related pink1 Model. M. Vos, B. Lovisa, A. Geens, V. A. Morais, G. Wagnières, H. Van Den Bergh, A. Ginggen, B. De Strooper, Y. Tardy and P. Verstreken. in PLoS ONE, vol. 8, num. 11, p. e78562, 2013. Etude préclinique des effets vasculaires induits par la thérapie photodynamique de nouveaux dérivés d’acide 5-aminolevulinique. S. Gay, C. Martoccia, J. Barge, P. Nowak-Sliwinska and G. Wagnières. in MRCT CNRS; Biophotonique, optique et diagnostic, p. 1-7, 2012. Reflectance imaging of the human retina at 810 nm does not suffice to optimize the parameters of hydrodynamic rebalancing laser treatment. F. Piffaretti, J.-P. Ballini, R. Perotti, M. Zellweger, E. Vezzola, M. Sickenberg and G. Wagnieres. in Journal Of Biomedical Optics, vol. 17, num. 11, p. 116027-1-10, 2012. Real-time, in vivo measurement of tissular pO(2) through the delayed fluorescence of endogenous protoporphyrin IX during photodynamic therapy. F. Piffaretti, A. M. Novello, R. S. Kumar, E. Forte, C. Paulou, P. Nowak-Sliwinska, H. Van Den Bergh and G. Wagnieres. in Journal Of Biomedical Optics, vol. 17, num. 11, p. 115007-1-9, 2012. Photoactive sawhorse-type diruthenium tetracarbonyl complexes. J. P. Johnpeter, F. Schmitt, E. Denoyelle-Di-Muro, G. Wagnieres, L. Juillerat-Jeanneret and B. Therrien. in Inorganica Chimica Acta, vol. 393, p. 246-251, 2012. Probing the Interaction Between a Surfactant-Cobalt(III) Complex and Bovine Serum Albumin. R. Senthil Kumar, H. van den Bergh and G. Wagnières. in Journal of Solution Chemistry, vol. 41, num. 2, p. 294-306, 2012. Angiogenesis inhibition by the maleimide-based small molecule GNX-686. P. Nowak-Sliwinska, M. Storto, T. Cataudella, J.-P. Ballini, R. Gatz, M. Giorgio, H. van den Bergh, S. Plyte and G. Wagnieres. in Microvascular Research, vol. 83, p. 105-110, 2012. Study of the pO2-sensitivity of the dendrimeric and free forms of Pd-meso-tetra(4-carboxyphenyl)porphyrin, incorporated or not in chitosan-based nanoparticles. P. Nowak-Sliwinska, P. Käuper, H. van den Bergh and G. Wagnières. in Chimia, vol. 65, num. 9, p. 691-695, 2011. Optical fiber-based setup for in vivo measurement of the delayed fluorescence lifetime of oxygen sensors. F. M. Piffaretti, K. Santhakumar, E. Forte, H. van den Bergh and G. A. Wagnières. in Journal of Biomedical Optics, vol. 16, num. 3, p. 037005, 2011. Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity. P. Nowak-Sliwinska, V. Beijnum, R. Judy, A. Casini, A. A. Nazarov, G. Wagnières, H. van den Bergh, P. J. Dyson and A. W. Griffioen. in Journal of Medicinal Chemistry, vol. 54, num. 11, p. 3895-3902, 2011.